Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Applied Twice or Three Times Daily in Patients With Acute Ankle Sprain

NCT00955513 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

242

Enrollment

INDUSTRY

Sponsor class

Conditions

Grade I/II Ankle Sprain

Interventions

DRUG: diclofenac diethylamine gel 2.32%
DRUG: diclofenac diethylamine gel 2.32%
DRUG: Placebo

Sponsor

Novartis